This study evaluates adding surgery (radical or partial nephrectomy) to standard immunotherapy-based drug treatments for patients with metastatic renal cancer.
Contact phone
(517) 364-2835
Contact email
[email protected]
Principal investigator
Dr. Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Metastatic Renal
Webform